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Summary
Evidence for genetic influences in epilepsy is strong, but
reports identifying specific chromosomal origins of those
influences conflict. One early study reported that human
leukocyte antigen (HLA)markers were genetically linked
to juvenile myoclonic epilepsy (JME); this was confirmed
in a later study. Other reports did not find linkage to
HLAmarkers. One found evidence of linkage tomarkers
on chromosome 15, another to markers on chromosome
6, centromeric to HLA. We identified families through
a patient with JME and genotyped markers throughout
chromosome 6. Linkage analysis assuming equal male-
female recombination probabilities showed evidence for
linkage (LOD score 2.5), but at a high recombination
fraction (v), suggesting heterogeneity. When linkage
analysis was redone to allow independent male-female
vs, the LOD score was significantly higher (4.2) at a
male-female v of .5, .01. Although the overall pattern
of LOD scores with respect to male-female v could not
be explained solely by heterogeneity, the presence of het-
erogeneity and predominantly maternal inheritance of
JME might explain it. By analyzing loci between HLA-
DP and HLA-DR and stratifying the families on the basis
of evidence for or against linkage, we were able to show
evidence of heterogeneity within JME and to propose a
marker associated with the linked form. These data also
suggest that JME may be predominantly maternally in-
herited and that the HLA-linked form is more likely to
occur in families of European origin.
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Introduction
The problems in finding genes that contribute to the
expression of common, complex diseases have become
more apparent as different groups report conflicting
findings. One of the first common diseases for which a
probable locus was identified was juvenile myoclonic
epilepsy (JME [MIM 254770]), a syndrome of the group
called the “idiopathic generalized epilepsies” (IGE).
These epilepsies do not originate in one spot in the brain
(as does “focal” epilepsy) but manifest over the whole
brain simultaneously (hence, “generalized”). The causes
of the IGE are uncertain but are thought to be largely
genetic (Greenberg et al. 1992; Janz et al. 1992)
The genetics of these epilepsies and the relationship
among them has become murkier as more loci contrib-
uting to their expression are reported. Greenberg et al.
(1988) reported evidence for linkage of JME to the hu-
man leukocyte antigen (HLA) region of chromosome 6,
which was later confirmed ( Durner et al. 1991; Weiss-
becker et al. 1991), and the locus was designated EJM1
(Greenberg et al. 1989). Sander et al. (1997a) recon-
firmed strong evidence for linkage of JME toHLA.How-
ever, Whitehouse et al. (1993) detected some evidence
for linkage in the HLA region (LOD score ∼1.4) at a
high recombination fraction (v), but it was not consid-
ered statistically significant. Later, Elmslie et al. (1997)
found evidence of linkage of JME to chromosome 15,
in an area in which an acetylcholine receptor subunit
was known to exist. However, Neubauer et al. (1998)
found evidence of linkage to Rolandic epilepsy—a focal,
not generalized, form of epilepsy—to this same region
of chromosome 15, whereas Sander et al. (1997b) and
Durner et al. (in press) found no evidence supporting
linkage of JME to any chromosome 15 loci. Further
adding to the confusion, Liu et al. (1995) reported link-
age of a large JME pedigree from Belize to markers on
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chromosome 6, but in a region ∼36 cM centromeric to
HLA. However, both Elmslie et al. (1996) andGreenberg
et al. (1998) failed to find any evidence suggesting link-
age of JME to markers centromeric to HLA. Finally,
Durner et al. (1992), Obeid et al. (1994), Greenberg et
al. (1995), and Moen et al. (1995) found evidence of
association of JME and HLA alleles.
The apparently contradictory evidence involving link-
age of JME suggests heterogeneity as a major influence
in these studies. Sander et al. (1997a) reported significant
evidence of linkage of JME to HLA markers in a sample
of German families. However, JME families they col-
lected elsewhere in the world gave evidence against link-
age, suggesting that linkage of JME to the HLA region
might represent a European phenomenon. The findings
of Liu et al. (1996) appear to support this hypothesis.
Thus, ethnic factors may play a role in finding linkage
in epilepsy.
Heterogeneity represents a major analysis problem be-
cause it significantly reduces the power to detect linkage
in a data set. Measures to reduce heterogeneity at the
clinical level are essential in common disease genetics.
Analysis programs that take account of ‘‘admixture’’
heterogeneity are of some aid, but testing for linkage
heterogeneity by using hypotheses based on clinical dif-
ferences is a more powerful approach. Durner et al.
(1999) showed that families separated on the basis of
clinical criteria yielded significant evidence of linkage,
whereas simply assuming admixture heterogeneity in an
analysis including all families failed to yield a level of
significance that would even qualify as interesting. Our
approach in the current study was to reduce heteroge-
neity in JME by analysis of families ascertained through
a carefully diagnosed JME case, then to test the hy-
pothesis of linkage of JME to HLA-region markers with
a new series of families. Expansive data analysis then
ultimately yielded clues about heterogeneity that we
could exploit to reveal the phenomena complicating the
linkage results.
Families and Methods
Family Data
All families were ascertained through at least one JME
index case. The major inclusion criterion was the pres-
ence of myoclonic jerks, involving the arms and shoul-
ders, that occur upon or shortly after affected individuals
awaken from sleep. These jerks are experienced with full
consciousness. The age at onset of seizures was 18 years
and !20 years. Findings from the neurologic examina-
tion and magnetic resonance imaging (MRI) or com-
puted tomography (CT) scans were normal (Commis-
sion on Classification 1989). To reduce instances of
other epilepsy syndromes, we excluded families when
the index patient had (1) myoclonic absences (absences
accompanied by rhythmic [3/s] jerking) or atonic at-
tacks, (2) focal seizures, (3) alcohol or other substance
abuse, (4) mental retardation, or (5) any suggestion that
the epilepsy was the result of a structural, metabolic, or
degenerative disease.
We ascertained 85 JME cases (48 of which ultimately
provided information for linkage at HLA). Seven pa-
tients had myoclonic jerks as their only seizure type; 78
had myoclonic jerks plus tonic-clonic seizures, and 21
also had juvenile-onset absence seizures (short staring
episodes lasting a few seconds and occurring a few times
a day). Informed consent was obtained for all partici-
pants.
Family Members
Although all families were ascertained through a JME
patient, 28 families had an additional family member or
members with JME or other forms of IGE. Family mem-
bers with any form of confirmed IGE were classified as
affected. All available family members were given 1-h
electroencephalograms (EEGs). Fourteen family mem-
bers who were clinically normal but with spike-and-
wave EEG or paroxysmal bursts of generalized high-
amplitude slow waves in the theta range (in the presence
of a normal awake background rhythm) were also clas-
sified as affected. In previous work (Greenberg et al.
1988; Durner et al. 1991; Sander et al. 1997a), the ab-
normal EEGs in normal family members appear to be
genetically related to the epilepsy phenotype. Thus, fam-
ilies are ascertained through a JME patient, but family
members are counted as affected if they have any IGE
or a generalized EEG abnormality of the type seen in
IGE cases, making the overall phenotype broader than
just JME.
Patients with Other (Non-JME) Forms of IGE
To look for association of markers with JME, we an-
alyzed patients with forms of IGE different from JME.
These patients were ascertained through the same clinics,
from the same populations, and in the same manner as
the JME index patients. The non-JME patients had IGE
syndromes similar in many respects to JME (juvenile
absence, tonic-clonic seizures, and adolescent age at on-
set; see Durner et al. [1999] for an extensive description)
but lacked the awakening myoclonic jerks. Families with
these non-JME forms of IGE yielded strong evidence
against linkage with HLA (Greenberg et al. 1996). There
were 38 index patients with non-JME forms of epilepsy.
These forms show evidence of linkage to markers on
chromosome 8 (Durner et al. 1999), whereas JME shows
significant evidence against linkage to the same markers.
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Table 1
LOD Scores for the DQB1 Locus and JME, Allowing Independent
Male-Female vs
vm
LOD Score at vf =
.01 .05 .1 .2 .3 .4 .5
.5 4.218 4.057 3.723 2.771 1.654 .637 .000
.4 4.181 4.018 3.684 2.732 1.620 .607 .022
.3 4.041 3.877 3.543 2.595 1.490 .491 .118
.2 3.695 3.534 3.205 2.265 1.171 .191 .383
.1 2.944 2.797 2.481 1.559 .479 .469 .974
.05 2.259 2.126 1.823 .919 .140 1.049 1.481
.01 1.274 1.164 .886 .032 .957 1.753 —2.058
Genetic Markers
We typed markers along the entire length of chro-
mosome 6 and additional markers within the HLA
region. The markers we typed were (telomere)
D6S344–F13A–D6S309–D6S277–D6S470–D6S260–
D6S289–D6S422–D6S299–D6S258–D6S1621–
D6S265–D6S306–D6S273–DRB1–DQA1–DQB1–
D6S1666–D6S1610–D6S271–D6S257–D6S286–
D6S460 –D6S462 –D6S434 –D6S287 –D6S262 –
D6S292–D6S441–D6S1581–D6S264–D6S281. The
majority of these markers were from the ABI marker
panel (Perkin-Elmer). Others, mostly in the HLA region,
were selected from Dib et al. (1996).
Linkage Analysis
We performed both two-point and multipoint linkage
analyses. LIPED (Ott 1974) was used for two-point anal-
ysis, allowing independent male and female vs (vm, vf).
GENEHUNTER (Kruglyak et al. 1996) was used for
multipoint analysis. We did the multipoint analyses both
with and without allowing for heterogeneity.
Following previous reports of linkage of HLAmarkers
to JME (Durner et al. 1991; Greenberg et al. 1992), we
assumed dominant inheritance with 70% penetrance in
the HLA region. Even moderate changes in the value of
the assumed penetrance will often not greatly affect the
value of the final LOD score in an analysis (Greenberg
1989). When analyzing the rest of the chromosome, we
assumed both dominant and recessive inheritance, each
with a penetrance value of 50%, as recommended by
Hodge et al. (1997). Extensive work has demonstrated
that the LOD score statistic has the most power to detect
linkage in complex disease, even when any increase in
type I error is taken into account (Greenberg et al. 1998;
Abreu et al. 1999).
Because the HLA-DRB and HLA-DQB loci are highly
polymorphic, we did not expect that inclusion of ad-
ditional HLA-region markers under multipoint analysis
would provide further linkage information in the HLA
region beyond that provided by DR and DQ. (The po-
tential advantage of multipoint analysis lies in extraction
of more information for linkage by combination of allele
information from adjacent but less-informative mark-
ers.) We typed additional markers in the HLA region to
look for recombinants, thus narrowing the region con-
taining the EJM1 locus.
Results
Linkage Data
As the study progressed, the analyses of the data con-
sistently yielded maximum LOD scores at (thev = .01f
lowest tested) and (indicating no linkage). Al-v = .5m
though the genetic length of this region of chromosome
6 is approximately twice as great in females as in males
(Cooperative Human Linkage Center database), that
would not explain the observation of the difference in
vm and vf at the maximum LOD score in our family data.
Initially, we assumed that difference in vm and vf was due
to small sample size, but, as the sample size grew and
the position of the maximum did not change, we were
forced to the conclusion that the phenomenon was real.
Table 1 shows the grid of LOD scores for the analysis
with independent male-female vs. The maximum LOD
score was 4.2 at . (The maximum LOD scorev = .5,.01m,f
along the diagonal [ ]) is 2.5 at a v estimate of .1.)v = vm f
Even with correction for the increase in type I errorwhen
independent male-female vs are used, which requires
subtraction of .5 from the maximum LOD score (Lander
and Lincoln 1988), the LOD score is highly significant.
Moreover, this is the third data set reporting linkage of
JME to the HLA region. An affected-only analysis
yielded a LOD score of 2.76 at .v = .5,.05m,f
Superficially, this result implies that there is little re-
combination (i.e., close linkage) in females but indepen-
dent segregation of disease and marker (i.e., no linkage)
in males. Such a finding might suggest maternal trans-
mission of the disease allele— that is, that affected family
members usually share a maternal marker allele. How-
ever, the expected pattern of LOD scores, with indepen-
dent male and female vs under maternal transmission,
would show no variation with respect to vm (e.g., the
same LOD score value for all assumed vm at a given vf)
and variation only with respect to vf. Our results show
a great deal of variation of the LOD score with vm. One
explanation for the pattern we observe is that there exists
admixture of two types of families, with the linked form
showing maternal inheritance and with the other form
being unlinked.
Linkage analyses reported in the literature usually as-
sume equal male and female vs. In table 1, LOD scores
for equal male-female vs are seen on the diagonal (bot-
tom left to top right). The maximum LOD score along
the diagonal is 2.5 at a v estimate of .1. This estimate,
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Figure 1 Multipoint LOD scores for JME on chromosome 6, showing curves both with and without the assumption of heterogeneity.
if taken at face value, would put EJM1 beyond the HLA
region. However, the fact that the maximum LOD score
occurs at a high v when previous results (and the mul-
tipoint analysis) had put the gene within the HLA region
provides another suggestion of heterogeneity in the data
(Ott 1991; P. C. Abreu, D. A. Greenberg, and S. E.
Hodge, unpublished data). A multipoint LOD score
analysis of chromosome 6, assuming heterogeneity,
yielded a LOD score of 2.3 for the HLA region, with
an estimated a (the percentage of families linked) of 50%
(fig. 1). The multipoint LOD score assumed . Thisv = vm f
maximum LOD score value is close to the two-point
maximum LOD score when is assumed. Thus,v = vm f
both the two-point analysis and the multipoint analysis
at suggest heterogeneity.v = vm f
Analysis of Recombinants
Analysis of recombinations seen in the families we
studied showed a clear recombinant in one family be-
tween DQ and DP (fig. 2). Sander et al. (1997a) had
reported a recombinant centromeric to DQ in one of the
families in their study. Taken together, these two recom-
binant events mean that the EJM1 locus is likely to be
centromeric of DQ and telomeric of DP. The known
expressed loci in this region are DNA, RING3, DMA,
DMB, LMP2, TAP1, LMP7, TAP2, and DOB.
The existence of heterogeneity complicates the deter-
mination of which of the possible candidates may be
EJM1. Since it is essential to try to separate the hy-
pothesized linked from the unlinked form, we decided
to see whether an allele of a marker locus in the region
between DQ and DP was associated with JME probands
from families showing positive evidence of linkage com-
pared with “controls” (probands from non-JME fami-
lies). If a particular allele occurred more frequently
among the JME patients showing linkage than among
controls, then the distribution of alleles among the non-
EJM1 form of JME might be similar to the distribution
found in non-JMEs. This might lead to a marker for the
two different forms of JME.
Use of Association Data to Resolve the Heterogeneity
Having shown strong evidence for linkage and, si-
multaneously, for heterogeneity, we sought a means to
distinguish the EJM1-influenced JME from the non-
EJM1 form. Previous reports suggested an association
of JME with HLA alleles. Durner et al. (1992), Obeid
et al. (1994), and Greenberg et al. (1996) reported an
association of JME with DR alleles. In the Greenberg et
al. (1996) report, DQ alleles showed a somewhat
stronger association than did DR alleles.
With the increased data, we again looked at the DR
and DQ association with JME. We no longer detect an
association with DR13. Taking DQB1*603 and 604 to-
gether, we observe a nonsignificant x2 of 3.1 ( ).P ! .078
However, we know that we also now have substantial
heterogeneity in the data set, making an association
more difficult to detect.
We analyzed the 18 JME families showing the highest
positive LOD scores (range 0.1–1.4) for linkage with the
DRB1 marker. We then compared the distribution of
alleles in the families showing positive linkage with the
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Table 2
Differences in Allele Frequencies between Probands in JME Families with Positive
LOD Scores versus Probands from Families with Other Forms of IGE for the
DQB1 and RING3 Loci
Locus and Allele
JME
(n)
non-JME
(n)
JME
(%)
non-JME
(%) x2
DQB1
603604 6 4 16.8 4.1
Other 30 94 83.3 96.7 6.03 (P ! .02, 1 df)
Total 36 98 100 100
RING3
3 18 18 50.00 23.68
4 16 50 44.5 65.79
Other 2 8 5.5 10.3 8.7 (P ! .025, 2 df)
Total 36 76 100 100
Table 3
LOD Scores for the DQB1 Locus Allowing Independent Male-
Female v in CA.RING3.3+ Families
vm
LOD Score at vf =
.01 .05 .1 .2 .3 .4 .5
.5 3.4314 3.1727 2.7983 1.9565 1.1073 .4019 .0000
.4 3.4708 3.2124 2.8400 2.0031 1.1605 .4617 .0648
.3 3.6024 3.3431 2.9714 2.1417 1.3104 .6251 .2397
.2 3.7720 3.5134 3.1447 2.3254 1.5075 .8373 .4664
.1 3.9182 3.6648 3.3027 2.4967 1.6916 1.0344 .6782
.05 3.9616 3.7125 3.3557 2.5574 1.7586 1.1055 .7562
.01 3.9718 3.7278 3.3758 2.5851 1.7900 1.1397 .7950
distribution in probands from the non-JME families. The
distribution of DRB1 alleles was not different in the
index cases from the linked-only families and the non-
JME families. There was a significant difference in the
distribution of DQB603 and 604, with a .17 frequency
of 603 and 604 in the linked-only probands compared
with .04 in the non-JME cases ( ; ) (ta-2x = 6.04 P ! .014
ble 2). However, despite the continued evidence for as-
sociation, the number of linked-only JME cases with the
603 and 604 alleles was too small to use them as the
basis for a subset for linkage.
We searched for other polymorphic marker loci in the
region. We discovered a CA repeat located in the middle
of the RING3 locus, referred to below as CA.RING3
(GenBank accession number AF107699). Amplification
of this microsatellite region revealed six alleles, two of
which comprised 91% of the total (table 2). We ex-
amined the distribution of these alleles in the linked-
JME versus non-JME patients and noted that the fre-
quency of allele 3 (CA.RING3.3) was .5 in the patients
from families showing linkage and .24 in the non-JME
cases. Although the difference in the allele distribution
between the two groups was significant ( ;2x = 8.7 P !
, 2 df), our main purpose was not to demonstrate.025
a statistically significant association but to find a means
to divide the families in a way that could help unravel
the heterogeneity.
Combining Linkage and Association Data
We then applied the partitioned linkage-association
(PAL) test (Greenberg and Doneshka 1996). This test
requires division of the families into two groups, on the
basis of the presence or absence of the associated allele
in the index patient, and performance of separate linkage
analyses in the two groups. We divided the JME families
on the basis of the presence (CA.RING3.3) or absence
(CA.RING3.3) of the CA.RING3.3 allele. We then
performed linkage analysis separately on the two groups.
We observed, first, that the vs at which the maximum
LOD score occurred in the CA.RING3.3 group
changed from to .01,.01 and, second, thatv v = .5,.01m f
the LOD score rose from 1.27 to 3.97 at those v values
(table 3). Recall that analysis of the entire sample
showed a maximum LOD score of 1.3 at v = .01,.01m,f
(table 1). The CA.RING3.3 group (table 4) became
negative (2.43; multipoint LOD score 7 [fig. 3]).
Also, the CA.RING3.3 group showed little variation
with respect to vm, in contrast to the analysis of the
undivided group (table 1). If inheritance is usually ma-
ternal, this is what one expects to see, whether the cause
is biological or due to ascertainment bias. Removal of
the heterogeneous families resolved the apparent anom-
aly that the maximum LOD score occurred at v =m,f
. The multipoint maximum LOD score was 3.4 for.5,.01
CA.RING3.3 families [fig. 3]). When we performed a
statistical test for heterogeneity (Morton 1955) between
the RING3 and RING3 groups, based on the LOD
scores assuming equal male-female vs, x2 was 6.77
( , 1 df).P ! .01
These results may also explain the findings of
Whitehouse et al. (1993), who found a LOD score of
1.4 in the HLA region, at a high v value. Those authors
did not test independent male-female vs. Had they done
Greenberg et al.: Juvenile Myoclonic Epilepsy 513
Figure 2 Pedigree of a family with epilepsy, showing a recombinant (box) between DQ and DP, suggesting that EJM1 lies distal to DP.
Table 4
LOD Scores for the DQB1 Locus Allowing Independent Male-Female vs in
CA.RING3.35 Families
vm
LOD Score at vf =
.01 .05 .1 .2 .3 .4 .5
.5 .8106 .9045 .9406 .8231 .5511 .2360 .0000
.4 .7423 .8339 .8681 .7457 .4704 .1540 .0797
.3 .4950 .5863 .6189 .4929 .2136 .1028 .3274
.2 .0229 .1167 .1505 .0217 .2609 .5743 .7777
.1 .8041 .7031 .6636 .7894 1.0709 1.3661 1.5160
.05 1.4842 1.3744 1.3273 1.4435 1.7113 1.9719 2.0566
.01 2.4313 2.3038 2.2373 2.3129 2.5159 2.6667 2.6286
so, they might have found a pattern similar to that re-
ported here.
Other Findings on Chromosome 6
Region identified by Liu et al. (1995).—We paid par-
ticular attention to markers D6S271, D6S257, and
D6S460, ∼36 cM centromeric of HLA. Liu et al (1995)
reported significant evidence of linkage in a JME family
from Belize in this area. Two-point LOD scores for these
markers ranged from 6 (D6S271) to 1.5 (D6S460).
Multipoint LOD scores ranged from 7 to 4 (fig. 1).
LOD scores assuming heterogeneity were ∼0 (fig. 1).
Division of the families on the basis of whether absence
seizures were present in the family (Liu et al. 1996) also
did not yield any positive evidence for linkage (multi-
point LOD score 2 to 4).
A possible locus on 6q.—We noted a small positive
LOD score for JME in the region of D6S287, on the
long arm of chromosome. 6. The LOD score value for
all JME families was 1.9 and was essentially the same
when we allowed for heterogeneity (2.1, ).a = .87
Discussion
Our results yield three major findings: (1) We have
been able to replicate linkage of JME to HLA-region
markers, making this the third independent data set
showing strong evidence for linkage. (2) We demon-
strated heterogeneity in the data and were able to pro-
pose a marker that could separate the HLA-linked and
unlinked forms of JME. The CA.RING3 marker had an
allele occurring in 76% of probands from families show-
ing positive evidence for linkage but only 47% among
probands with other forms of IGE and 31% among JME
patients from families not showing evidence for linkage.
(3) The linkage pattern implied the existence not only
of heterogeneity but also of transmission predominantly
from mothers; this observation was strengthened when
we separated the families on the basis of the presence
of CA.RING3.3. This finding suggests that the mater-
nally inherited EJM1 either is more penetrant or is pref-
erentially transmitted by the mother in those families.
The observation of maternal transmission of epilepsy
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Figure 3 Multipoint linkage analysis for families in which the index patient was CA.RING3.3 or CA.RING3.3
has long been noted in the literature (Ottman et al. 1985,
1988). However, although the linkage data and epide-
miologic data suggest a biological basis for the maternal
transmission, ascertainment bias cannot be ruled out.
For ascertainment bias to account for our observations,
mothers with epilepsy in their families would have to
have been three times as likely to participate in the study
as were fathers with epilepsy in their families. We found
that, in families with epilepsy in two or more generations
or in which IGE was present in relatives (enabling us to
assign the origin to one side of the family or the other),
there were 25 instances in which IGE was likely to come
from the mothers’ family but only 7 such instances on
fathers’ sides (Klotz et al. 1999). This does not rule out
ascertainment bias but makes it less plausible.
Of interest, Weissbecker et al. (1991) also performed
linkage analysis assuming independent male-female vs.
Their LOD score maximized at a high female and low
male v ( ). However, the difference betweenv = .001,.2m,f
that maximum LOD score and the one obtained for
was not statistically significant, whereas the dif-v = vf m
ference we obtained for the two maxima in the current
study was highly significant ( ).P ! .005
We noted the existence of a small peak in both the
two-point and the multipoint LOD scores (maximum
LOD score ∼2) on the long arm of chromosome 6, at
D6S287. Almost half the families yield LOD scores of
0 at this marker, in part because two alleles make up
∼60% of the total frequency. Further studies will con-
tinue to explore this region.
Another observation concerns ethnicity. Sander et al.
(1997a) noted that JME families from non-European
ethnic groups showed evidence against linkage to HLA,
suggesting that EJM1 may influence JME primarily in
European-origin families. We examined families on the
basis of ethnicity. The problem in a “melting pot” area
such as New York City is that ethnicity may be difficult
to determine. We had classified families broadly into
white (that is, European origin), black (based on skin
color and features), Hispanic (based on Spanish lan-
guage of the parents and South or Central American
origin), and Asian (Chinese, Japanese, or Indian origin).
The nonwhite families produced mostly negative LOD
scores (12/16 families had negative LOD scores, 4/16
had positive LOD scores), and the LOD score at all v
was negative and was 1.8 at . Althoughv = v = .01m f
we have limited data, our results, like those of Sander
et al. (1997a), suggest that the EJM1 form of JME occurs
mostly in families of European origin. The findings of
Liu et al. (1995) support this hypothesis.
These new results on chromosome 6 in JME must be
put into the perspective of all the genetic influences on
IGE and JME. Results from our genome scan in IGE
(M. Durner, M. A. Meddache, L. Tomasini, S. Shinnar,
S. R. Resor, S. L. Moshe, D. Rosenbaum, J. Cohen, C.
Harden, H. Kang, S. Wallace, D. Luciano, K. Ballaban-
Gil, I. Klotz, E. Dicker, D. A. Greenberg, unpublished
data) show that other genetic loci influence the expres-
sion of JME, perhaps as much as, or more strongly than,
the locus on chromosome 6. The demonstration of het-
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erogeneity within the JME syndrome means that the ep-
ilepsy syndromewe call JME is not a single genetic entity.
The genome scan and the existence of heterogeneity also
suggest that other loci besides EJM1 may produce the
symptom of myoclonic jerks, given that the locus or loci
predisposing to IGE are present. Results from our ge-
nome scan support the idea that EJM1 may act to de-
termine the type of seizures that will be manifested in a
patient who is genetically susceptible to IGE, rather than
being responsible for the IGE itself. This hypothesis is
supported by our observation of loci that appear to be
linked to absence seizures in both JME and non-JME
families (M. Durner, M. A. Meddache, L. Tomasini, S.
Shinnar, S. R. Resor, S. L. Moshe, D. Rosenbaum, J.
Cohen, C. Harden, H. Kang, S. Wallace, D. Luciano, K.
Ballaban-Gil, I. Klotz, E. Dicker, D. A. Greenberg, un-
published data).
Another observation is that, in common disease stud-
ies, a parochial analysis of linkage data canmiss evidence
for linkage (Hodge et al. 1993). Whether the difference
in vm and vf is due to biologic factors or to ascertainment
bias, the fact that the linkage could have been missed
without the data exploration afforded by the broader
analysis suggests that one must take a more expansive
view of the methods used to find linkage. Such an ap-
proach may be necessary to resolve inevitable contra-
dictory results from different studies.
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